
Israel agreed to treat the 1-year-old granddaughter of Hamas Prime Minister Ismail Haniyeh in Gaza for a rare malady but was unable to help her, officials said. The critically ill Amal Haniyeh underwent medical tests at the Schenider Medical Center in Petah Tikva Sunday but was brain dead when she arrived, Yedioth Ahronoth reported Tuesday. Maj. Guy Ibar, a spokesman for the Israeli coordinator for Government Activities in the Territories, told The Times of Israel his office received a call from the Palestinian liaison office, requesting Amal's transfer to an Israeli hospital for treatment after her condition deteriorated. After conducting a series of tests, doctors determined Amal's condition was incurable and she was returned to Gaza Monday afternoon, the Hebrew language daily said. Hamas, a terrorist group in control of the Gaza Strip, is at loggerheads with the predominantly Fatah-run Palestinian Authority and refuses to recognize Israel's right to exist. Hamas has said it will not be bound by any peace agreement between Israel and the Palestinians.
GMT 16:26 2018 Wednesday ,29 August
Morocco, Cuba Start 'Unprecedented and Historic Era' in their RelationsGMT 16:13 2018 Wednesday ,29 August
Morocco, Dominican Republic Discuss Means to Promote CooperationGMT 18:51 2018 Sunday ,21 January
Tensions mount in Rohingya camps ahead of planned relocation to MyanmarGMT 18:47 2018 Sunday ,21 January
Macron shares African outrage on Trump’s vulgar languageGMT 18:41 2018 Sunday ,21 January
Jordan urges Pence to rebuild trust after Jerusalem pivotGMT 18:37 2018 Sunday ,21 January
UN Security Council to discuss Syria on MondayGMT 18:23 2018 Sunday ,21 January
Iraqi court sentences to death German woman who joined DaeshGMT 18:19 2018 Sunday ,21 January
Turkish state media say Turkey’s ground forces have entered Syrian Kurdish enclave
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor